|
IGF2BP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.865360E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.627400E-01 |
| Normal-vs-Stage2 |
6.165000E-01 |
| Normal-vs-Stage3 |
3.175200E-01 |
| Normal-vs-Stage4 |
1.235630E-01 |
| Stage1-vs-Stage2 |
2.545400E-01 |
| Stage1-vs-Stage3 |
9.926000E-01 |
| Stage1-vs-Stage4 |
4.208000E-01 |
| Stage2-vs-Stage3 |
2.262400E-01 |
| Stage2-vs-Stage4 |
1.116030E-01 |
| Stage3-vs-Stage4 |
4.488400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.510300E-02 |
| Normal-vs-AfricanAmerican |
4.239600E-01 |
| Normal-vs-Asian |
4.992800E-01 |
| Caucasian-vs-AfricanAmerican |
1.047830E-01 |
| Caucasian-vs-Asian |
1.175440E-01 |
| AfricanAmerican-vs-Asian |
9.946000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.903900E-02 |
| Normal-vs-Female |
6.734600E-01 |
| Male-vs-Female |
3.277600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.061200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.613200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.719780E-01 |
| Normal-vs-Age(81-100Yrs) |
6.857600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.118200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.685360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.866600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.263600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.036000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.443400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.360000E-01 |
| Normal-vs-Grade 2 |
7.134600E-01 |
| Normal-vs-Grade 3 |
1.110280E-02 |
| Normal-vs-Grade 4 |
3.973600E-01 |
| Grade 1-vs-Grade 2 |
8.045200E-01 |
| Grade 1-vs-Grade 3 |
1.762640E-01 |
| Grade 1-vs-Grade 4 |
6.111600E-01 |
| Grade 2-vs-Grade 3 |
1.598370E-03 |
| Grade 2-vs-Grade 4 |
2.568400E-01 |
| Grade 3-vs-Grade 4 |
3.357200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.125400E-01 |
| Normal-vs-ccB subtype |
3.959200E-01 |
| ccA subtype-vs-ccB subtype |
7.584800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.858220E-01 |
| Normal-vs-N1 |
1.915600E-01 |
| N0-vs-N1 |
3.099000E-01 |
|
|
